Insulin
Insulin is produced by the beta cells of the islets of Langerhans in the pancreas. It consists of an A-chain of 21 amino acids and a B-chain of 30 aminoacids. Pro-insulin, the precursor of insulin, is a single polypeptide chain 1.5 times the size of insulin. It is cleaved into insulin and C-peptide which are therefore secreted in equimolar amounts. C-peptide levels reflect endogenous insulin secretion and are widely used for research purposes. About 3-5% of pro-insulin escapes the cleavage process and is secreted intact.
There are various types of insulin preparation used in the treatment of diabetes mellitus:
- very rapidly-acting insulin e.g. insulin lispro or insulin aspart
- short-acting e.g. human actrapid
- intermediate-acting insulin e.g. human insulatard
- long-acting-acting insulin
- mixtures containing specific proportions of short and intermediate-acting insulins
Commercial insulin is generally recombinant human insulin; although animal insulins are still available.
All commercial insulins come in a strength of 100 units/ml.
Notes:
- long-acting human insulin analogue are an alternative to intermediate-acting insulin
Related pages
- Preparations
- Pancreatic beta cell physiology
- Functions
- Indications for insulin
- Complications of insulin therapy
- Initial doses of insulin in the newly diagnosed diabetic
- Insulin regimens in insulin-dependent diabetes mellitus
- NICE guidance - the use of long-acting insulin analogues for the treatment of type 2 diabetes - insulin glargine and insulin detemir
- Insulin regimes in Type 2 diabetes
- Insulin - human to analogue transfer
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.